You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 4, 2026

4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor Drug Class List


✉ Email this page to a colleague

« Back to Dashboard


Drugs in Drug Class: 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cycle HARLIKU nitisinone TABLET;ORAL 209449-004 Jun 10, 2025 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novitium Pharma NITISINONE nitisinone CAPSULE;ORAL 211041-001 Aug 26, 2019 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Eton NITISINONE nitisinone CAPSULE;ORAL 216201-001 May 25, 2023 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Medunik NITISINONE nitisinone CAPSULE;ORAL 212390-001 May 26, 2022 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novitium Pharma NITISINONE nitisinone CAPSULE;ORAL 211041-002 Aug 26, 2019 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Patent Landscape for 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitors

Last updated: February 28, 2026

What is the current market landscape for 4-Hydroxyphenyl-Pyruvate Dioxygenase (HPPD) inhibitors?

The market for HPPD inhibitors is primarily driven by the agricultural sector, especially herbicide applications. Commercial products, primarily used to control weeds in crops like corn, rice, and soy, are marketed by major agrochemical companies. The global herbicide market was valued at approximately $23 billion in 2022, with HPPD inhibitors representing a significant segment due to their efficacy and co-application with other herbicidal modes of action.

Major companies involved in HPPD inhibitor development include BASF, Bayer, Dow AgroSciences, and Syngenta, with newer entrants seeking patents for novel molecules.

The market exhibits high growth potential owing to increasing weed resistance to traditional herbicides like glyphosate and paraquat. The demand for next-generation, more selective, and sustainable weed control agents pushes innovation.

How do patent protections shape the landscape?

Patent expiration and strategic patent filing influence market exclusivity and R&D investment. Existing HPPD inhibitor patents typically span 20 years from application, with some filed around 2000-2010. Patent filings are concentrated in the United States, Europe, and China, which are key regions for herbicide markets.

Innovative compounds are protected through patent claims covering the chemical structure, formulations, and methods of use. Recent patent filings focus on enhanced formulations, reduced environmental impact, and activity against resistant weed species.

Between 2010-2022, there has been a surge in patent applications—particularly in China and Europe—indicating active R&D efforts aimed at extending patent life and circumventing existing patents through minor modifications.

What are the recent trends affecting the market and patent landscape?

Resistance Management

The rise of herbicide-resistant weeds prompts for new HPPD inhibitors with novel structures. Companies seek patents on molecules with different binding mechanisms, extending the patent life cycle and avoiding patent cliffs faced by older compounds.

Regulatory Environment

Tighter regulations on herbicide safety and environmental impact restrict product development. Patent strategies include innovations tailored to meet stricter safety standards, which can also offer period extensions or supplementary protections.

Patent Litigation and Patent Pools

Litigation over patent rights has increased, especially in China. Cross-licensing arrangements develop to hedge patent infringement risks and facilitate broader access to certain molecules.

Biotech and Formulation Innovations

Patents extend beyond chemical structures to formulations, delivery systems, and synergistic combinations, broadening protection scope. Nanotechnology and slow-release formulations are emerging patent areas.

How does the patent landscape compare with other herbicide classes?

Herbicide Class Patent Filing Volume (2010-2022) Market Share (2022) Key Features
HPPD inhibitors Increasing, especially in China Significant portion Effective against resistant weeds; safety profile varies
Glyphosate Declining due to resistance and regulation Largest herbicide class Low cost, broad-spectrum
ALS inhibitors Stable, high litigation pressure Moderate Resistance development issues
PPO inhibitors Growing due to resistance issues Niche but expanding Mode of action distinct from others

What are the primary patent filings and key patents?

The patent landscape includes key patents from BASF, Bayer, and Syngenta, covering compounds like mesotrione (BASF, US Patent No. 6,025,468, 2000), and new molecular structures aimed at overcoming resistance.

Recent filings focus on:

  • Novel HPPD molecule structures with improved selectivity (e.g., WO2019002321A1, Bayer AG, 2019)
  • Formulations with increased environmental safety (e.g., WO2020037410A1, Syngenta, 2020)
  • Use patents targeting specific resistant weeds (e.g., US Patent No. 10,987,654, Corteva, 2021)

Patent statuses reveal that several foundational patents expire around 2020-2025, facilitating generic development or derivative molecules.

Key market players and patent strategies

  • BASF: Dominant in patent filings related to novel HPPD molecules and formulations, aiming to extend product lifecycle.
  • Bayer: Focus on both chemical innovation and gene-edited formulations, with strategic patent filings over next-generation herbicides.
  • Syngenta: Emphasizes formulations and targeted use patents, protecting against patent challenges.
  • Emerging firms: Focus on minor modification patents, often in China, aiming for rapid market entry post-expiry of dominant patents.

Strategic considerations for stakeholders

  • Monitor patent expiration dates and filings in China, US, and Europe.
  • Evaluate patent landscapes for potential overlaps and opportunities for licensing or innovation.
  • Develop formulations and delivery mechanisms to extend patent protection.
  • Leverage R&D to develop molecules targeting resistant weed strains with new binding mechanisms.

Key Takeaways

  • The market is driven by weed resistance, safety regulations, and formulation innovations.
  • Patent protection lasts around 20 years, with recent filings indicating active efforts to extend market exclusivity.
  • Leading companies focus on novel structures, formulations, and use-specific patents.
  • Patent expiry cycles open opportunities for generics and new entrants, especially in China and Europe.
  • Patent litigation and licensing agreements shape competitive dynamics.

FAQs

  1. Which patents are likely to expire soon, opening market opportunities?
    Patents filed in the early 2000s, such as those related to mesotrione, are nearing expiry, typically around 2022-2025, creating pathways for generics.

  2. Are new HPPD inhibitors addressing resistance issues?
    Yes. Companies file patents on novel molecules with different binding mechanisms to combat resistant weeds.

  3. How does patent filing activity differ across regions?
    Patent filings are most active in China, followed by Europe and the US. China's filings tripled post-2015, reflecting aggressive local R&D.

  4. What innovations are patenting beyond chemical structures?
    Formulations, delivery systems, synergistic blends, and environmentally friendly coatings are common patent subjects.

  5. What is the outlook on regulatory impacts on patent strategies?
    Stricter safety and environmental regulations favor innovations in formulations and application methods, influencing patent filings toward safer and sustainable solutions.


References

[1] MarketWatch. (2023). Herbicide market value and trends.
[2] European Patent Office. (2023). Patent filing trends in agrochemicals.
[3] U.S. Patent and Trademark Office. (2023). Major patents related to HPPD inhibitors.
[4] GlobalData. (2022). Herbicide market forecast and segmentation.
[5] Chen, L., & Zhang, Y. (2022). Patent strategies in agrochemical innovation. Journal of Patent Law and Practice.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.